|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
112,320,000 |
Market
Cap: |
48.31(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.4301 - $0.4301 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Avalo Therapeutics is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology and rare genetic diseases. Co.'s clinical-stage pipeline include: AVTX-002, which is developing for the treatment of non-eosinophilic asthma, inflammatory bowel disease; AVTX-007, which is developing AVTX-007 for the treatment of Still's Disease; AVTX-801, which is a D-galactose substrate replacement therapy for the treatment of phosphoglucomutase 1 deficiency; and AVTX-803, which is a L-fucose substrate replacement therapy for the treatment of LADII.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
37,351 |
662,763 |
Total Buy Value |
$0 |
$0 |
$139,843 |
$643,635 |
Total People Bought |
0 |
0 |
3 |
4 |
Total Buy Transactions |
0 |
0 |
10 |
32 |
Total Shares Sold |
0 |
0 |
5,291,542 |
5,291,542 |
Total Sell Value |
$0 |
$0 |
$3,199,077 |
$3,199,077 |
Total People Sold |
0 |
0 |
2 |
2 |
Total Sell Transactions |
0 |
0 |
4 |
4 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Boyd Steven |
10% Owner |
|
2017-08-23 |
4 |
B |
$0.62 |
$557 |
D/D |
900 |
15,735,765 |
2.37 |
- |
|
Boyd Steven |
10% Owner |
|
2017-08-22 |
4 |
B |
$0.62 |
$23,790 |
I/I |
38,602 |
15,734,865 |
1.5 |
- |
|
Boyd Steven |
10% Owner |
|
2017-08-22 |
4 |
B |
$0.62 |
$11,895 |
D/D |
19,301 |
15,734,865 |
2.37 |
- |
|
Boyd Steven |
Director |
|
2017-08-21 |
4 |
B |
$0.61 |
$19,069 |
I/I |
31,128 |
15,715,564 |
2.17 |
- |
|
Boyd Steven |
Director |
|
2017-08-21 |
4 |
B |
$0.61 |
$9,535 |
D/D |
15,564 |
15,715,564 |
3.84 |
- |
|
Boyd Steven |
Director |
|
2017-08-18 |
4 |
B |
$0.61 |
$38,615 |
I/I |
63,396 |
15,700,000 |
2.25 |
- |
|
Boyd Steven |
Director |
|
2017-08-18 |
4 |
B |
$0.61 |
$19,307 |
D/D |
31,698 |
15,700,000 |
3.92 |
- |
|
Boyd Steven |
Director |
|
2017-08-17 |
4 |
B |
$0.59 |
$30,490 |
I/I |
52,004 |
15,668,302 |
2.25 |
- |
|
Boyd Steven |
Director |
|
2017-08-17 |
4 |
B |
$0.59 |
$15,245 |
D/D |
26,002 |
15,668,302 |
3.92 |
- |
|
Boyd Steven |
10% Owner |
|
2017-08-16 |
4 |
B |
$0.58 |
$89,088 |
I/I |
153,600 |
15,642,300 |
1.5 |
- |
|
Boyd Steven |
10% Owner |
|
2017-08-16 |
4 |
B |
$0.58 |
$44,544 |
D/D |
76,800 |
15,642,300 |
2.37 |
- |
|
Boyd Steven |
10% Owner |
|
2017-08-15 |
4 |
B |
$0.58 |
$75,980 |
I/I |
131,000 |
15,565,500 |
1.5 |
- |
|
Boyd Steven |
10% Owner |
|
2017-08-15 |
4 |
B |
$0.58 |
$37,990 |
D/D |
65,500 |
15,565,500 |
2.37 |
- |
|
Boyd Steven |
10% Owner |
|
2017-08-14 |
4 |
B |
$0.64 |
$224,993 |
I/I |
351,552 |
15,500,000 |
1.5 |
- |
|
Boyd Steven |
10% Owner |
|
2017-08-14 |
4 |
B |
$0.64 |
$112,497 |
D/D |
175,776 |
15,500,000 |
2.45 |
- |
|
Boyd Steven |
Director |
|
2017-07-06 |
4 |
OE |
$0.35 |
$8,358,000 |
I/I |
23,880,000 |
15,324,224 |
|
- |
|
Boyd Steven |
Director |
|
2017-07-06 |
4 |
OE |
$0.35 |
$4,179,000 |
D/D |
11,940,000 |
15,324,224 |
|
- |
|
Hacksell Uli |
Director |
|
2017-06-09 |
4 |
B |
$0.42 |
$4,200 |
D/D |
10,000 |
20,000 |
2.31 |
- |
|
Boyd Steven |
Director |
|
2017-05-19 |
4 |
B |
$0.63 |
$30,522 |
I/I |
48,448 |
3,384,224 |
2.25 |
- |
|
Boyd Steven |
Director |
|
2017-05-19 |
4 |
B |
$0.63 |
$15,261 |
D/D |
24,224 |
3,384,224 |
3.92 |
- |
|
Boyd Steven |
10% Owner |
|
2017-05-11 |
4 |
B |
$0.74 |
$127,461 |
I/I |
172,244 |
3,360,000 |
1.5 |
- |
|
Boyd Steven |
10% Owner |
|
2017-05-11 |
4 |
B |
$0.74 |
$63,730 |
D/D |
86,122 |
3,360,000 |
2.45 |
- |
|
Boyd Steven |
10% Owner |
|
2017-05-10 |
4 |
B |
$0.79 |
$43,954 |
I/I |
55,638 |
3,273,878 |
1.5 |
- |
|
Boyd Steven |
10% Owner |
|
2017-05-10 |
4 |
B |
$0.79 |
$21,977 |
D/D |
27,819 |
3,273,878 |
2.37 |
- |
|
Boyd Steven |
10% Owner |
|
2017-05-09 |
4 |
B |
$0.66 |
$47,598 |
I/I |
72,118 |
3,246,059 |
1.5 |
- |
|
440 Records found
|
|
Page 16 of 18 |
|
|